site stats

Topigen pharmaceuticals inc

WebNov 2, 2005 · MONTREAL, Canada and RANDOLPH, N.J., Nov. 2 /PRNewswire/ -- TOPIGEN Pharmaceuticals Inc., an emerging biopharmaceutical company specializing in respiratory … WebAug 14, 2008 · MONTREAL--(MARKET WIRE)--Aug 14, 2008 -- TOPIGEN Pharmaceuticals Inc., a clinical-stage biopharmaceutical company specialized in developing products for respiratory disorders, today announced that it has appointed Mark Parry-Billings, Ph.D., as Chief Executive Officer. Dr. Parry-Billings joined TOPIGEN in 2007 as Chief Development …

Topigen Pharmaceuticals Company Profile: Acquisition

WebTopigen Pharmaceuticals offers TPI ASM8, a drug that is developed for the management of moderate to severe asthma; and TPI 1100, a drug that is developed for the chronic obstructive pulmonary disease. Topigen Pharmaceuticals was acquired by Pharmaxis in January 2010. Topigen Pharmaceuticals was founded in 2000 and is based in Montreal, … WebJun 6, 2024 · A former Director of Research in Pharmacology at Topigen Pharmaceuticals, Inc, over twenty years of research experience, Dr. Ferrari is the co-inventor of six patents. Rosanne Seguin, PhD, is an Academic Associate at the Montreal Neurological Institute of McGill University, Montreal, Quebec, Canada. A former Director of Immunology and ... transdermal skin moisturizing https://gftcourses.com

Topigen Pharmaceuticals Inc. Begins IND-Enabling Studies For …

WebTopigen Pharmaceuticals has raised a total of CA$28.6M in funding over 2 rounds. Their latest funding was raised on Oct 10, 2005 from a Series B round. Topigen Pharmaceuticals is funded by 6 investors. Caisse de Depot et Placement du Quebec and T2C2 Capital are the most recent investors. Topigen Pharmaceuticals has acquired Anagenis on Mar 25 ... WebTraductions en contexte de "emprunt (plus" en français-anglais avec Reverso Context : Les investisseurs dans Topigen Pharmaceutiques Inc., dans le cadre de divers projets de financement par actions et par emprunt (plus de 75 millions de dollars) et … WebCompanies; Gentaur USA Gentaur UK Gentaur Spain; 547 Yurok Cir San Jose, CA 95123, USA Phone/Fax: (408) 780-0908 Email: [email protected] / [email protected] gentaur.com Unicorn House, Station Cl Hertfordshire, Potters Bar EN6 1TL transdnjestr

Oligonucleotide-Based Drugs and Therapeutics - Google Books

Category:Contact Us – Topigen Pharmaceuticals, Respiratory Research

Tags:Topigen pharmaceuticals inc

Topigen pharmaceuticals inc

Topigen Pharmaceuticals - Crunchbase Company Profile …

WebFounded Date 1996. Founders Elisabeth Robinson, John L. Wallace, Michele Garufi. Operating Status Active. Last Funding Type Post-IPO Equity. Stock Symbol EPA:COX. Company Type For Profit. Contact Email [email protected]. Phone Number 33 4 97 24 53 00. NicOx is a biopharmaceutical company, engages in the development and … WebPatents Assigned to Topigen Pharmaceuticals, Inc. Antisense oligonucleotides for treating allergy and neoplastic cell proliferation. Patent number: 8202851 Abstract: Antisense oligonucleotides for treating and/or preventing at least one of asthma, allergy, hypereosinophilia, general inflammation and cancer are provided. The oligonucleotides …

Topigen pharmaceuticals inc

Did you know?

WebNov 20, 2007 · SOPHIA ANTIPOLIS, France, Nov. 20 /PRNewswire/ -- NicOx S.A. (Eurolist: COX) today announced that TOPIGEN Pharmaceuticals Inc. has dosed the first patients in a phase 2 proof of concept study for TPI 1020 in Chronic Obstructive Pulmonary Disease (COPD) - see TOPIGEN press release attached. This new study is expected to provide the … WebTopigen Pharmaceuticals offers TPI ASM8, a drug that is developed for the management of moderate to severe asthma; and TPI 1100, a drug that is developed for the chronic obstructive pulmonary disease. Topigen Pharmaceuticals was acquired by Pharmaxis in January 2010. Topigen Pharmaceuticals was founded in 2000 and is based in Montreal, …

WebTopigen Pharmaceuticals offers TPI ASM8, a drug that is developed for the management of moderate to severe asthma; and TPI 1100, a drug that is developed for the chronic obstructive pulmonary disease. Topigen Pharmaceuticals was acquired by Pharmaxis in January 2010. Topigen Pharmaceuticals was founded in 2000 and is based in Montreal, … WebCompanies; Gentaur USA Gentaur UK Gentaur Spain; 547 Yurok Cir San Jose, CA 95123, USA Phone/Fax: (408) 780-0908 Email: [email protected] / [email protected] gentaur.com …

WebAug 29, 2007 · NovaQuest has made a strategic investment in TOPIGEN Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company specializing in respiratory disorders. The investment was part of a private placement of C$26M (US$25M) in … WebSolco Healthcare U.S., headquartered in Somerset, New Jersey, is an industry leader in marketing and distributing generic pharmaceuticals. Solco is committed to providing our …

WebSep 18, 2006 · MONTREAL and PARSIPPANY, NJ -- (MARKET WIRE) -- September 18, 2006 -- TOPIGEN Pharmaceuticals Inc., an emerging biopharmaceutical company specializing in developing treatments for respiratory diseases, today announced that it has selected its next clinical candidate for Chronic Obstructive Pulmonary Disease (COPD). The compound, TPI …

WebInnovatech Grand Montréal is a venture capital investment firm. transdoc suzukiWebJan 11, 2010 · Jan 11, 2010, 11:45 ET. MONTREAL , Jan. 11 /CNW Telbec/ - TOPIGEN Pharmaceuticals Inc., a Canadian-based clinical-stage biopharmaceutical company focused on innovative respiratory therapeutics ... transdoc zacapaWebDr. Wotton served as the Chairman of the Emerging Companies Advisory Board of BIOTECanada. He has been a Director of Antares Pharma Inc., since August 16, 2004 and Genaera Corp. since June 2008. He served as Executive Director of Topigen Pharmaceuticals Inc. until March 2008. He is a Member of the Royal Pharmaceutical … transdnjestrija